A relationship between pre-and postimplantation monaural auditory performance in SCI recipients was not identified. The first implanted ear is more likely to exhibit better monaural auditory performance, even if this ear had worse preimplantation hearing. This finding highlights the plasticity of central auditory pathways in cochlear implant recipients.
Otology/Neurotology
Motion Sickness Treatment Analysis with OVAR Glenn W. Knox, MD, JD (presenter) Objective: Evaluation of transdermal scopolamine for motion sickness prophylaxis.
Method: Randomized, prospective double blind. 2010-11. Twelve patients, 7 male, 5 female, ages 21 to 57. Intervention(s): Off-vertical axis rotation 20° in the dark after administration of transdermal scopolamine or placebo. Outcome measures: Duration of tolerated off-vertical rotation; subjective symptom reporting at 1-minute intervals on a 0 to 4 scale.
Results:
Patients treated with transdermal scopolamine had statistically significant improved tolerance time to off-vertical axis rotation. Reported symptomatology on the 0-3 subjective symptom scale was significantly improved as compared to placebo and was dose-dependent. These results were significant to the .05 confidence level.
Conclusion:
Off-vertical axis rotation is a useful modality for the evaluation of motion sickness medications. Transdermal scopolamine showed statistically significant dose-dependent effects in mitigating OVAR-induced motion sickness symptomatology and was well tolerated.
Otology/Neurotology Novel Completely-in-the-Canal Magnet-Drive Micro Hearing Aid
Hossein Mahboubi, MD, MPH (presenter); Peyton Paulick; Saman Kiumehr, MD; Mark Merlo, MD; Mark Bachman, MD; Hamid R. Djalilian, MD Objective: To describe a novel magnet-drive micro hearing aid (MMHA), a 3.5-mm wide device, that fits entirely into the bony canal and drives the tympanic membrane (TM) using a magnet in a noncontact fashion. To test the effectiveness and optimal positioning of the magnet on the TM.
Method: Cadaveric temporal bones were prepared for laser Doppler vibrometry (LDV) of the stapes. MMHA was placed at 1 and 2 mm away from the TM, and the magnets were glued to umbo and lateral process of the malleus. Frequency sweeps between 300 Hz to 12 kHz were performed.
Results:
The MMHA showed frequency response from 300 Hz to 12 kHz at loudness levels from 60 to 120 dBA at 10 dBA steps. Placement of magnet on the umbo resulted in higher amplitudes and lower power requirements than placement on the lateral process. The same results were observed when the device was placed at 1-mm distance from the TM.
Conclusion: MMHA is a small completely-in-the-canal hearing aid that drives the TM in a noncontact fashion through a magnet. This novel device has a frequency output wider than air conduction devices. The device's ability to directly drive the TM enables it to potentially sound more naturally and similar to implantable devices.
Otology/Neurotology
Otoacoustic Emission in Noise-Exposed Normal Hearing Workers Andre L.L. Sampaio, MD, PhD (presenter); Marlene E. Boger; Carlos A.C.P. Oliveira, MD
Objective: Otoacoustic emission test is useful in monitoring hearing changes and cochlear damage by noise still not detectable in pure-tone audiometry.The aim was to evaluate amplitude of the signal and signal/noise ratio of distortion product otoacoustic emissions (DPOAE) in normal hearing workers exposed to different noise doses.
Method: This is a cohort prospective study performed in metalworking industries, in 3 groups of normal hearing workers, GI not exposed (n = 50), GII sporadically exposed (n = 50), and GIII often exposed to occupational noise (n = 50). DPOAE were performed after 14 hours of hearing rest. "Pass-fail" criterion was employed for analyses.
Results: Six hundred eight workers underwent hearing thresholds, and 150 of them matched the inclusion criteria and had DPOAE recorded. DPOAE alterations in amplitude of signal and signal to noise ratio were found in groups II and III bilaterally, and the higher the frequency tested the lower were the results in GII and GIII (P < .05). The greater the exposure to noise dose the lower the results (P < .05). GI showed better results according to pass and fail criterion and higher amplitude of the signal and signal/ noise ratio than GII and GIII (P < .05).
Conclusion: DPOAE results are worse in the exposed groups according to occupational noise dose. It is important to search for undetectable hearing changes in all workers exposed to occupational noise even sporadically, and to encourage the use of hearing protectors, in order to prevent possible irreversible damage.
Otology/Neurotology Outcomes after Usage of Ponto implant System
Seilesh Babu, MD (presenter); Brian J. McKinnon, MD, MBA; Michael J. Fucci, MD Objective: Bone-anchored hearing systems have proven to be an effective amplification solution for conductive, mixed, and profound unilateral sensorineural hearing losses. The Ponto bone-anchored hearing system has been available in the United States for 2 years.
Method: This multicenter study was performed to review our experience with the Ponto system in 99 patients from 3 medical
